This case study describes a 34-year-old male developing painful inflammatory scalp nodules post-scalp microinfusion of medication. The findings suggest that repeated microtrauma or bacterial colonization might trigger dissecting cellulitis in susceptible individuals, with exogenous testosterone as a potential modifier, not a direct cause.
September 2021 in “CRC Press eBooks” This review discusses dissecting cellulitis of the scalp and reports no new clinical findings.
1 citations
,
September 2023 in “Dermatology and therapy” This review explores the efficacy and safety of treatments for dissecting cellulitis of the scalp, revealing a predominance of case reports and series, and concludes that randomized controlled trials are needed for better evidence-based therapies.
January 2023 in “Dermatologic therapy” This study found that dissecting cellulitis of the scalp was more common in young men, with an association between longer disease duration and increased severity, but no link between age and severity.
16 citations
,
April 2017 in “Pediatric Dermatology” In this case report, an 18-year-old male with dissecting cellulitis of the scalp, characterized by painful nodules and hair loss, showed successful treatment outcomes with oral isotretinoin therapy.
33 citations
,
December 2013 in “Journal of cutaneous pathology” A fungal infection can look like a different scalp condition in teens, leading to wrong treatment until proper tests are done.
17 citations
,
August 2018 in “Journal der Deutschen Dermatologischen Gesellschaft” This study found that dissecting folliculitis is more common than previously thought in Taiwan, with obesity possibly linked to higher severity of this condition, but smoking not associated.
6 citations
,
October 2023 in “JAAD Case Reports” This study describes dissecting cellulitis of the scalp (DCS) as a rare and aggressive form of chronic scalp inflammation presenting with pustules and nodules, commonly affecting males and African Americans, and leading to significant quality of life impacts and psychological distress.
May 2025 in “Journal of Inflammation Research” In this case report, a 28-year-old Chinese man with severe dissecting cellulitis of the scalp experienced nodules resolution and hair regrowth after treatment with ixekizumab and tofacitinib, marking the first reported use of this drug combination for the condition.
June 2024 in “Australasian Journal of Dermatology” In this case study, a 13-year-old boy with dissecting cellulitis of the scalp showed improvement in inflammatory lesions and hair regrowth after treatment with isotretinoin, sublingual minoxidil, and oral prednisolone, marking the youngest reported male case of this condition.
July 2018 in “Elsevier eBooks” This study underscores the importance of using trichoscopy and histopathology for the differential diagnosis of primary neutrophilic cicatricial alopecias to facilitate early intervention and prevent cicatricial alopecia progression.
April 2026 in “Dermatology and Therapy” This study reviews the efficacy and safety of advanced therapies like TNFα inhibitors and IL-17/IL-23 inhibitors for dissecting cellulitis of the scalp, finding TNFα inhibitors particularly effective for severe or refractory cases, although prospective validation is needed for early intervention benefits.
March 2026 in “Biomedicines” This review synthesizes current evidence on therapies for dissecting cellulitis of the scalp, noting that biologics show promise for treatment-resistant cases, though systemic retinoids remain the first-line therapy.
May 2025 in “Orphanet Journal of Rare Diseases” This review suggests that immunomodulators, including TNF-α blockers and IL inhibitors, may improve symptoms of moderate-to-severe dissecting cellulitis of the scalp, but their effects on hair regrowth and scarring remain unclear.
1 citations
,
January 2026 in “International Journal of Dermatology” In this study, a case of dissecting cellulitis of the scalp was reported in a man after starting dupilumab therapy, highlighting potential immune pathways involved and the importance of recognizing such paradoxical inflammatory reactions to prevent irreversible alopecia.
51 citations
,
October 2002 in “Archives of dermatology” This case study of a patient with dissecting cellulitis of the scalp found that multiple medications, including isotretinoin, achieved only modest improvement, and symptoms returned after treatments were stopped.
1 citations
,
January 2024 in “Curēus” This case study reported significant clinical improvement in a 26-year-old male with dissecting cellulitis of the scalp after treatment with upadacitinib, suggesting that JAK inhibitors may be a promising option for refractory cases, where standard treatments have limited success.
February 2026 in “Dermatology Reports” In this case study, trichoscopy was found to be a valuable non-invasive tool for diagnosing dissecting cellulitis of the scalp, enabling early detection and intervention to prevent disease progression and reduce the need for invasive procedures.
This case report in the Journal of Drugs in Dermatology discusses dissecting cellulitis of the scalp, emphasizing its disproportionate impact on Black males and the need for early diagnosis and effective management to mitigate scarring and quality of life issues.
June 2023 in “British journal of dermatology/British journal of dermatology, Supplement” This case report describes a rare instance of dissecting cellulitis of the scalp in a White child, which is uncommon in pediatric cases and presented challenges in diagnosis and treatment.
36 citations
,
April 2005 in “British journal of dermatology/British journal of dermatology, Supplement” In this study, modern radiation therapy techniques rapidly alleviated pain and improved symptoms in patients with severe dissecting cellulitis of the scalp, with no long-term toxicity observed.
15 citations
,
November 2016 in “Journal of The American Academy of Dermatology” This article discusses the potential of trichoscopy in diagnosing and treating dissecting cellulitis of the scalp and emphasizes the need for early diagnosis to prevent progression but reports no new clinical results.
3 citations
,
May 2023 in “Pediatric Dermatology” This case report describes a 9-year-old boy with atypical alopecic and aseptic nodules of the scalp, suggesting possible inclusion within the spectrum of typical AANS and DCS due to its prepubertal onset and facial involvement.
2 citations
,
September 2023 in “JAAD Case Reports” This article discusses the chronic inflammatory skin diseases acne keloidalis nuchae and dissecting cellulitis of the scalp, focusing on their shared etiology and differing progression, and reports no new clinical findings.
July 2026 in “Dermatology and Therapy” This study highlights that dissecting cellulitis of the scalp affects a diverse racial population and is associated with male sex, metabolic dysfunction, and psychiatric comorbidities, challenging its traditional characterization as primarily a disorder of Black men.
May 2026 in “Frontiers in Immunology” This case report documents the first use of bimekizumab as monotherapy for dissecting cellulitis of the scalp, where a 27-year-old man experienced significant symptom relief without adverse effects after failing standard treatments.
In this case report, an 11-year-old girl with dissecting cellulitis of the scalp showed an excellent response to oral isotretinoin after other treatments failed, highlighting the treatment challenges and need for awareness in managing this rare condition.
October 2024 in “TURKDERM” Hair transplantation can lead to rare scalp complications, requiring careful follow-up and treatment.
Infliximab was effective in treating a scalp condition that did not respond to other treatments.
February 2023 in “Journal of the European Academy of Dermatology and Venereology”